US Patent Issued to Beckley Psytech on Jan. 27 for "Tryptamine analogues" (British Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,441, issued on Jan. 27, was assigned to Beckley Psytech Ltd. (Oxford, Great Britain).

"Tryptamine analogues" was invented by Massimo Muratore (Oxford, Great Britain), Amir Lotfi Moghaddam (Oxford, Great Britain), Vinod Vishwapathi (Oxford, Great Britain), Christopher Wong (Oxford, Great Britain) and Oliver Mcgaw (Oxford, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to pharmaceutically acceptable tryptamine analogues and salts thereof. In particular, though not exclusively, the invention relates to formulations and uses of the same as a medicament."

The patent was filed on Jan. 17, 2022, under Application No. 1...